by bmuc | Mar 10, 2020 | Meetings, News
The BMUC Board members regret to announce the cancellation of the annual BMUC congress planned for this coming 13-14 March 2020 due to the outbreak of COVID-19. We have carefully evaluated the situation from day to day but due to the most recent restrictions imposed...
by bmuc | Aug 9, 2018 | News
[ESMO 2018 Press Release] Date: 21 Oct 2018 Topic: Genitourinary cancers MUNICH, Germany – A combination of the immune checkpoint blocker, avelumab, plus the tyrosine kinase inhibitor (TKI), axitinib, significantly improves progression-free survival (PFS) in...
Recent Comments